Advertisement
New Zealand markets closed
  • NZX 50

    11,806.65
    -139.78 (-1.17%)
     
  • NZD/USD

    0.5959
    +0.0009 (+0.15%)
     
  • NZD/EUR

    0.5551
    +0.0011 (+0.19%)
     
  • ALL ORDS

    7,844.60
    -92.90 (-1.17%)
     
  • ASX 200

    7,583.50
    -99.50 (-1.30%)
     
  • OIL

    83.86
    +0.29 (+0.35%)
     
  • GOLD

    2,348.00
    +5.50 (+0.23%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,626.75
    +342.21 (+1.98%)
     
  • NIKKEI 225

    38,073.39
    +444.91 (+1.18%)
     
  • NZD/JPY

    93.0340
    +0.5380 (+0.58%)
     

JNJ’s Consumer Business Expected to Be Driven by Innovation

JNJ’s Consumer Business Expected to Be Driven by Innovation

Johnson & Johnson (JNJ) is scheduled to report its third-quarter earnings on October 16. The company’s second-quarter growth in its Consumer business was below expectations. However, it expects to accelerate the segment’s growth in the second half of the year, driven mainly by the introduction of new products. The company’s other two business segments are Pharmaceuticals and Medical Devices. Johnson & Johnson’s Consumer business consists of a range of products across its baby care, oral care, women’s health, beauty, wound care, and over-the-counter franchises.